Allergen receives positive opinion for IBS drug
Allergan plc today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Truberzi (eluxadoline) in the European Union. Trubberzi is an oral medication taken to relieve the main symptoms of irritable bowel syndrome with diarrhoea (IBS-D) in adults.
Click on this link for more information.
